Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies
Print Options
PrintThe Whole
Regulation
PrintThis
Annex
only
Changes over time for:
ANNEX I
Llinell Amser Newidiadau
Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.
Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.
Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.
Version Superseded: 01/07/2017
Status:
Point in time view as at 01/07/2013.
Changes to legislation:
There are currently no known outstanding effects by UK legislation for Regulation (EC) No 999/2001 of the European Parliament and of the Council,
ANNEX I
.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
[ANNEX I U.K. SPECIFIC DEFINITIONS
[1. For the purpose of this Regulation, the following definitions set out in Regulation (EC) No 1069/2009 of the European Parliament and of the Council () , Commission Regulation (EU) No 142/2011 () , Regulation (EC) No 178/2002 of the European Parliament and of the Council () , Regulation (EC) No 767/2009 of the European Parliament and of the Council () and Council Directive 2006/88/EC () shall apply: U.K.
(a)
the definition of ‘ farmed animal ’ in Article 3(6) of Regulation (EC) No 1069/2009;
(b)
the following definitions in Annex I to Regulation (EU) No 142/2011:
(i)
‘ fur animals ’ in point 1;
(ii)
‘ blood products ’ in point 4;
(iii)
‘ processed animal protein ’ in point 5;
(iv)
‘ fishmeal ” in point 7;
(v)
‘ collagen ” in point 11;
(vi)
‘ gelatine ” in point 12;
(vii)
‘ hydrolysed proteins ’ in point 14;
(viii)
‘ canned petfood ’ in point 16;
(ix)
‘ petfood ” in point 19;
(x)
‘ processed petfood ’ in point 20;
(c)
the definition of ‘ feed ’ in Article 3(4) of Regulation (EC) No 178/2002;
(d)
Regulation (EC) No 767/2009:
(i)
‘ feed materials ’ in Article 3(2)(g);
(ii)
‘ compound feed ’ in Article 3(2)(h);
(iii)
‘ complete feed ’ in Article 3(2)(i);
(e)
Directive 2006/88/EC:
(i)
‘ aquaculture animal ’ in Article 3(1)(b);
(ii)
‘ aquatic animal ’ in Article 3(1)(e).]
[2. For the purpose of this Regulation, the following definitions shall also apply: U.K.
(a)
‘ BSE indigenous case ’ means a case of bovine spongiform encephalopathy which has not been clearly demonstrated to be due to infection prior to importation as a live animal;
(b)
‘ cohort ’ means a group of bovine animals which includes both:
(i)
animals born in the same herd as the affected bovine animal, and within 12 months preceding or following the date of birth of the affected bovine animal; and
(ii)
animals which at any time during the first year of their lives were reared together with the affected bovine animal during the first year of its life;
(c)
‘ index case ’ means the first animal on a holding, or in an epidemiologically defined group, in which a TSE infection is confirmed;
(d)
‘ TSE in small ruminants ’ means a transmissible spongiform encephalopathy case detected in an ovine or caprine animal following a confirmatory test for abnormal PrP protein;
(e)
‘ scrapie case ’ means a transmissible spongiform encephalopathy confirmed case in an ovine or caprine animal where a diagnosis of BSE has been excluded in accordance with the criteria laid down in the European Union reference laboratory’s technical handbook on TSE strain characterisation in small ruminants () ;
(f)
‘ classical scrapie case ’ means a scrapie confirmed case classified as classical in accordance with the criteria laid down in the European Union reference laboratory’s technical handbook on TSE strain characterisation in small ruminants;
(g)
‘ atypical scrapie case ’ means a scrapie confirmed case which is distinguishable from classical scrapie in accordance with the criteria laid down in the European Union reference laboratory’s technical handbook on TSE strain characterisation in small ruminants;
(h)
‘ Prion protein genotype ’ in ovine animals means a combination of two alleles as described in point 1 of Annex I to Commission Decision 2002/1003/EC () ;
(i)
‘ BSE case ’ means a case of BSE confirmed in a national reference laboratory according to the methods and protocols in point 3.1.(a) and (b) of Chapter C of Annex X;
(j)
‘ classical BSE case ’ means a BSE case classified as such in accordance with the criteria laid down in the European Union reference laboratory’s method for the classification of bovine TSE isolates () ;
(k)
‘ atypical BSE case ’ means a BSE case which cannot be classified as a classical BSE case in accordance with the criteria laid down in the European Union reference laboratory’s method for the classification of bovine TSE isolates;
(l)
‘ ovine and caprine animals over 18 months of age ’ means ovine and caprine animals:
(i)
whose age is confirmed by the registers or movement documents referred to in point 1(b), (c) and (d) of Article 3 of Council Regulation (EC) No 21/2004 () , or
(ii)
which have more than two permanent incisors erupted through the gum.] ]
Yn ôl i’r brig